Home
Storia in 4 fonti
Novo Nordisk bids $9bn for obesity drug maker Metsera in challenge to Pfizer
US biotech viewed as lucrative target partly because of its promising pipeline of weight-loss drugs
- ·
cnbc.com
Novo Nordisk hijacks Pfizer with bid for U.S. biotech Metsera
Denmark's Novo Nordisk said on Thursday it has made an unsolicited bid for U.S. drug maker Metsera, after Pfizer last week made an offer for the company.
- ·
ft.com
Novo Nordisk gatecrashes Pfizer deal with $9bn bid for Metsera
Pfizer had struck deal in September to buy obesity-focused biotech
- ·
theguardian.com
Novo Nordisk bids $9bn for obesity drug maker Metsera in challenge to Pfizer
US biotech viewed as lucrative target partly because of its promising pipeline of weight-loss drugs
- ·
cincodias.elpais.com
Guerra de opa en el adelgazamiento: Novo Nordisk supera a Pfizer con su oferta por Metsera
El grupo danés presenta una oferta de 6.500 millones de dólares, por encima del importe ya acordado por su rival estadounidense. El mercado espera la respuesta de Pfizer
- ·
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Pfizer said Friday it filed a lawsuit against Metsera and Novo Nordisk saying Metsera breached its merger agreement obligations.
- ·
Battle for obesity biotech Metsera heats up as Pfizer sues to block rival bid
FTC fast-tracks antitrust approval of earlier deal in sign Washington could weigh in on takeover battle with Novo Nordisk